Genome-Wide Data Can Classify Gliomas Into Subtypes
Two studies show distinct molecular classes of gliomas based on genomic alterations
CNS Cancers
Anticoagulation Tx in Patients With Brain Metastases: Safety Assessed in Study
Therapeutic anticoagulation is safe for treating venous thromboembolism in patients with cancer that has metastasized to the brain, according to new research.
Risks of Whole Brain Radiation Tx May Outweigh Benefits
Targeted radiation in the treatment of brain metastases leads to less cognitive damage than radiation for the entire brain, while survival is similar, researchers reported at the annual meeting of the American Society of Clinical Oncology. In a second study, researchers report that early trials of a new form of gene therapy may give hope to patients battling glioblastoma.
Tetanus Shot May Prime Immune System for Brain Tumor Vaccine
A tetanus booster may play a role in priming the immune system to enhance a vaccine for lethal brain tumors, a study published in Nature has shown.
Unituxin Approval Leads to Rare Priority Review Voucher Award
The Food and Drug Administration (FDA) has granted a Rare Pediatric Priority Review Voucher (PPRV) as part of the Biologics License Application (BLA) approval for Unituxin (dinutuximab) for neuroblastoma.
First Tx for Pediatric High-Risk Neuroblastoma Approved
The Food and Drug Administration (FDA) has approved Unituxin (dinutuximab; United Therapeutics), the first therapy to be approved for pediatric patients with high-risk neuroblastoma for use as part of a multimodal regimen including surgery, chemotherapy and radiation therapy for patients who achieved at least a partial response to prior first-line multiagent, multimodality therapy.
Hormonal Contraceptives May Increase Brain Cancer Risk
But odds of any one user getting the tumor remain extremely small, experts stress
Avastin Gains New Ovarian Cancer Indication
Genentech announced that the Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with chemotherapy for the treatment of women with platinum-resistant, recurrent ovarian cancer.
Nearly 1 in 20 Cancer Patients Die Within Month of Surgery
In a study of more than 1.1 million cancer patients who had surgery, Harvard researchers found that almost 5% died within one month of their operation.
ASTRO Issues Second List of Choosing Wisely Guidelines
The American Society for Radiation Oncology (ASTRO) has released a second list of five radiation oncology-specific treatments that should be discussed before being prescribed.
